# NBank Capital

> NBank Capital is a VC fund in Hanover backing Software, Apps and Travel. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hanover, Germany
- Total investments: 8
- Last investment: Sep 2025
- Lead investor: 50%
- Last updated: Aug 2026
- Website: https://www.nbank-capital.de/

NBank Capital is a VC fund in Hanover focused on Software and Apps. NBank Capital invests in young, innovative companies in the seed and startup phase, N investments in SMEs with capital requirements for growth.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $891k–$3.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 38% |
| Apps | 2 | 25% |
| Travel | 2 | 25% |
| Tourism | 2 | 25% |
| Mobile Apps | 2 | 25% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 75% |
| Series A | 1 | 13% |
| Venture - Series Unknown | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BIOWEG | Founded in Germany in 2019, Bioweg is a purpose-driven company, matches BioInnOvation to business problems. Their research combine biotechnology, material science, and molecular simulation learning to develop and sell B2B advanced sustainable and bio-based high-performance ingredients. Their ingredients are 100% animal-free, globally scalable, andsustainably manufactured with green chemistry. The company partners with results-driven, forward-thinking companies and consumer brands with global reach in cosmetics, personal care, agricultural technology, and food/beverage sectors. Bioweg's innovative zero-waste circular process uses food industry waste as feedstock to produce bio-based microbeads, rheology modifiers and hydrocolloids that are completely free of microplastics and comply with the new ECHA regulation. | $19M | Series A | Sep 16, 2025 |  |
| Allogenetics | Allogenetics GmbH provides a unique solution to the problem of organ rejection following transplantation. It is a distinct first-in-class therapy since it addresses the transplant rather than paralyzing the patient's immune system. | $3.8M | Seed | Aug 29, 2024 |  |
| Lignopure GmbH | In Lignopure we produce natural degradable biopolymers from non-food sources. Our Lignopure product is the best-of-its-kind lignin, with proven non cytotoxicity and added functionality. No other lignin in the market can offer the safety of Lignopure and the tailored properties achieved through our protected technology. From the raw materialproduction, we are able to deliver tailored lignin for different applications; these include particles for cosmetics, pharmaceuticals and food supplements. Additionally, our biobased prototypes include insulating materials, biobased polyurethane foams, aerogels and filaments for 3D printing. | $2.6M | Seed | Jul 17, 2024 |  |
| Flexxter | Flexxter offers a cooperation platform on which companies can plan together and communicate efficiently. | $900K | Seed | May 17, 2023 |  |
| VisioLab | VisioLab combines human-centric artificial intelligence with the responsibility of making data-driven decisions in order to establish a more sustainable agricultural economy. VisioLab was founded by Tim Niekamp and Justin Shenk. | $2.1M | Seed | Jan 10, 2023 |  |
| Cruisewatch | Cruisewatch is an AI-based travel tech company. This is why for every inefficiency in the cruise industry we aim to find a technological solution. And our team constantly works on improving those travel innovations. | $1.1M | Venture - Series Unknown | Mar 04, 2022 |  |
| Lambus | Lambus is changing the way people organize their trips by participating in every step of the travel process. | $890.6K | Seed | Mar 01, 2022 |  |
| NautilusLog | NautilusLog is adapted to the needs of the maritime industry and helps you to combine the mandatory reports and tracking with innovative technology. | $1.2M | Seed | Feb 17, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [APX](https://shizune.co/investors/profile/apxberlin) — VC Fund, 1 deal together
- [Axeleo Capital](https://shizune.co/investors/profile/axeleo-sas) — VC Fund, 1 deal together
- [BONVENTURE](https://shizune.co/investors/profile/bonventure) — VC Fund, 1 deal together
- [Carma Fund](https://shizune.co/investors/profile/carma-fund) — VC Fund, 1 deal together
- [European Innovation Council Fund](https://shizune.co/investors/profile/european-innovation-council-fund) — VC Fund, 1 deal together
- [European regional development fund (ERDF)](https://shizune.co/investors/profile/european-regional-development-fund-erdf) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [HOWZAT Partners](https://shizune.co/investors/profile/howzat-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Travel Investors in Germany](https://shizune.co/investors/travel-investors-germany)
- [Travel VC Funds in Germany](https://shizune.co/investors/travel-vc-funds-germany)
- [Mobile Apps VC Funds in Germany](https://shizune.co/investors/mobile-apps-vc-funds-germany)

## FAQ

### What does NBank Capital invest in?

NBank Capital invests primarily in Software, Apps and Travel startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is NBank Capital's check size?

NBank Capital typically joins rounds of $891k–$3.8M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NBank Capital participates in.

### When did NBank Capital last invest?

The most recent investment recorded for NBank Capital closed in Sep 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co